Minnetonka, MN, United States of America

Victor Ivan Chornenky

This inventor holds 57 USPTO granted patents and 1 published patent application, primarily in Electroporation Therapy (CPC class A61N). Top assignees: Minnesota Medical Physics LLC, Angiodynamics, Inc., Medtronic Ave, Inc.. Active years: 1996-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victor Ivan Chornenky. Retrieved from https://idiyas.com/inventor/victor-ivan-chornenky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 57 

% Patents Active = 70.2

Average Co-Inventor Count = 2.2

ph-index = 30

Forward Citations = 3,934(Granted Patents)

Forward Citations (Not Self Cited) = 3,792(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Santa Rosa, CA (US) (2002 - 2006)
  • Minnetonka, MN (US) (1996 - 2023)

Company Filing History:


Years Active: 1996-2023

Loading Chart...
Areas of Expertise:
Electroporation
Cancer Treatment
X-Ray Apparatus
Benign Prostatic Hyperplasia
Diabetic Retinopathy
Chronic Kidney Disease
Osteoarthritis
Subcutaneous Fat Reduction
Tumor Treatment
Hair Removal
Thermal Stimulation
Field Emission X-Ray
57 patents (USPTO):Explore Patents

Title: Victor Ivan Chornenky: Pioneering Innovations in Cancer and Prostate Treatment

Introduction

Victor Ivan Chornenky is an accomplished inventor located in Minnetonka, MN, with a remarkable portfolio of 57 patents. His contributions to medical technologies, especially in the fields of cancer treatment and benign prostatic hyperplasia (BPH), reflect his dedication to enhancing patient care through innovative solutions.

Latest Patents

Chornenky's latest patents showcase his innovative approaches to complex medical challenges. One notable invention is a method and apparatus for cancer treatment, which integrates systemic delivery of A3 selective adenosine receptor (A3AR) agonists, such as CI-IB-MECA, and cordycepin with simultaneous pulsed Electric Field (EF) stimulation. This method is designed to significantly increase the expression of A3ARs on cellular membranes, resulting in a downstream apoptotic signal that is exponentially stronger compared to the effects of the agonist drugs alone.

Another significant patent is focused on the treatment of benign prostatic hyperplasia (BPH). This invention utilizes a set of coils that generate multidirectional pulsed electromagnetic fields specifically aimed at the prostate. The apparatus includes a power source, an intelligent controller, and an applicator that generates these fields based on the controller's instructions. The technology targets cellular interactions to enhance the anti-inflammatory actions of the adenosine A2aAR pathway.

Career Highlights

Victor Ivan Chornenky has worked with notable companies in the medical field, including Minnesota Medical Physics LLC and Medtronic Ave, Inc. His experience in these organizations has contributed to his extensive expertise in developing groundbreaking medical devices and treatment methods.

Collaborations

Throughout his career, Chornenky has collaborated with various professionals, including colleagues Ali Jaafar and Graham Steven Kerslick. These partnerships have facilitated the exchange of ideas and expertise, resulting in the advancement of innovative solutions in medical treatment.

Conclusion

Victor Ivan Chornenky stands out as a leading inventor whose work is pushing the boundaries of medical technology. His innovative patents, particularly in oncology and urology, underscore his commitment to improving health outcomes for patients. As research in these fields progresses, Chornenky's contributions will undoubtedly have a lasting impact on future treatment methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…